Amit Hazan
Stock Analyst at Goldman Sachs
(2.75)
# 1,264
Out of 4,667 analysts
95
Total ratings
100%
Success rate
11.75%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $186.31 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $11.46 | -78.18% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.43 | +1,233.33% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $12.45 | -35.72% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $51.48 | +22.38% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $224.92 | +20.93% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $19.75 | -13.92% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $34 → $29 | $0.71 | +3,961.62% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $94.52 | -53.45% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $70.74 | +3.19% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $33.07 | +60.29% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $46.33 | +23.03% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $10.20 | -6.82% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $116.92 | -11.05% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $13.43 | +346.76% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $84.92 | +35.43% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $389.04 | -61.44% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $91.57 | -49.76% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $550.30 | -56.08% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $108.57 | +63.03% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $155.49 | -5.46% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.88 | +107.45% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $186.31
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $11.46
Upside: -78.18%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.43
Upside: +1,233.33%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $12.45
Upside: -35.72%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $51.48
Upside: +22.38%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $224.92
Upside: +20.93%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $19.75
Upside: -13.92%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $34 → $29
Current: $0.71
Upside: +3,961.62%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $94.52
Upside: -53.45%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $70.74
Upside: +3.19%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $33.07
Upside: +60.29%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $46.33
Upside: +23.03%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $10.20
Upside: -6.82%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $116.92
Upside: -11.05%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $13.43
Upside: +346.76%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $84.92
Upside: +35.43%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $389.04
Upside: -61.44%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $91.57
Upside: -49.76%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $550.30
Upside: -56.08%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $108.57
Upside: +63.03%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $155.49
Upside: -5.46%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.88
Upside: +107.45%